PLN Gene Cardiomyopathy, Hypertrophic, Type 18 Genetic Test in UAE | 2800 AED | DHA Guidelines

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM – 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The PLN gene test identifies pathogenic variants in phospholamban linked to hypertrophic cardiomyopathy type 18, a hereditary cardiac muscle disorder. This next‑generation sequencing (NGS) assay provides definitive molecular confirmation for UAE patients at familial risk, enabling early clinical intervention and cascade screening.

Feature	Our NGS Test	Closest Alternative (Standard Panel)
Precision	99.9% analytical sensitivity & specificity	~95% due to lower coverage
Methodology	NGS (Next‑Generation Sequencing) with full PLN gene coverage	Limited Sanger sequencing or targeted hot‑spot analysis
Turnaround Time	3 to 4 Weeks	6–8 Weeks
Regulatory Alignment	DHA/MOHAP Standards, ISO 9001:2015	Variable

Physician Insight & Safety Protocols

"Understanding the genetic underpinnings of hypertrophic cardiomyopathy empowers families to make informed health decisions. This comprehensive NGS analysis provides precise data, but it is vital that results are contextualized within a complete cardiological assessment. Never adjust your prescribed medications without direct consultation with your treating specialist."

— Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License No. 9294403

Clinical Safety Advisory

This test is strictly an elective genetic risk assessment tool. It is not a substitute for emergency cardiac care. Patients presenting with acute symptoms such as chest pain, palpitations, or fainting must seek immediate hospital-based evaluation. All results should be reviewed with a board-certified cardiologist or clinical geneticist to guide therapeutic strategies and family cascade screening.

Patient Exclusion Criteria

Do not use this test if you are currently experiencing an acute cardiac event or medical emergency.
Do not stop taking any prescribed heart medications prior to testing without the explicit approval of your doctor.
Testing is contraindicated if the patient cannot provide informed consent or does not have access to post-test genetic counselling.
Home phlebotomy may be restricted in certain remote areas; contact us to verify coverage.

Patient FAQ & Clinical Guidance

1. What is the PLN gene test used for?

The PLN gene test identifies mutations in the phospholamban gene that cause hypertrophic cardiomyopathy type 18, enabling definitive diagnosis and family risk assessment.

2. How is the sample collected?

A blood sample, extracted DNA, or a dried blood spot on an FTA card is collected by a trained phlebotomist. DNA Labs UAE offers a premium VIP mobile phlebotomy service with temperature-controlled cold-chain transport, available daily from 8 AM to 11 PM.

3. How long do the results take and what do they mean?

Results are typically available within 3 to 4 weeks following sample receipt. A positive result indicates the presence of a pathogenic variant in the PLN gene, which informs clinical management, lifestyle modifications, and cascade screening for at-risk relatives. Results must be interpreted by a qualified healthcare professional.

4. What is the cost and does insurance cover this test?

The test price is 2,800 AED. DNA Labs UAE provides direct billing verification with most major UAE insurers. Please contact us via WhatsApp at +971 54 548 8731 to confirm your coverage.

UAE Regulatory & Data Privacy Adherence

Accreditation & Compliance: DNA Labs UAE strictly adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures and patient consent protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under the regulatory purview of the Dubai Health Authority (DHA) and the Ministry of Health and Prevention (MOHAP).

Clinical & Logistical Metadata

Test Name	PLN Gene Cardiomyopathy, Hypertrophic, Type 18 Genetic Test
Price (AED)	2,800
Turnaround Time	3 to 4 Weeks
Sample Type / Matrix	Whole Blood, Extracted DNA, or FTA Card Spot
Methodology Used	Next-Generation Sequencing (NGS)
ICD-10-CM Code	I42.1
LOINC Code	93935-3
DHA Facility License & Lab Address	DNA Labs UAE \| DHA License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE